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Thus the effects of MCT-induced pulmonary hypertension on responsiveness of pulmonary artery to vasodilator 
drugs with different mechanisms of action varied. The loss in potency of the nitrovasodilator, NP, is unlikely to be due 
to a reduced relaxant effect of cyclic GMP because there was no less in potency for AP (which also acts through cyclic 
GMP albeit via membrane rather than soluble guanylate cyclase). It is not yet known whether the increase in 
vasodiiator potency seen for PIN in this model of pulmonary hypertension will be shared by other potassium channel 
opening drugs. It was not seen for NIC, a drug which like pinacidil can open membrane potassium charnels but this 
may be because any increase in potency associated with this mechanism could be overridden by a decrease in potency 
associated with its additional properties resembling those of the nitrovasodilators. 
The PA/AO selectivity seen for PIN in vessels from rats with pulmonary hypertension i duced by MCT but not in 
controls, suggests that it may be worthwhile to investigate pinacidil, and possibly other potassium channel opening 
drugs, in patients with pulmonary hypertension where other drugs have proved inadequate. 
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The present study was conducted to investigate the systemic and regional haemodynamic effects of the newly 
synthesized potassium channel opener EMD 52692 (n ffi 7) or its solvent (n = 7) after intravenous administration i
anaesthetized pigs. Infusion ¢f the, solvent did not affect systemic haemodynamics (baseline values i'or heart rate, mean 
arterial blood pressure, cardiac output, systemic vascular esistance, left ventricular end diastolic blood pressure and 
left ventricular dP/dtma x were 99 + 6 beats min - i ,  89 + 5 mmHg, 2.8 + 0.2 1 min -I, 34 + 4 mmHg.min 1 -~, 6 + 1 
mmHg and 2670 + 170 mmHg s-1, respectively). Consecutive 10 min intravenous infusions of EMD 52692 (0.15, 0.30, 
0.60, 1.20 ~g kg- ] min-1) caused a dose-dependent decrease in mean arterial blood pressure from 90 + 3 to 44 + 4 
mmHg. This was entirely due to peripheral vasodilatation (decrease in systemic vascular esistance from 31 + 3 
Table 1 
Effec~ of intravenous infusiom of EMD 52692 (/tg kg -! min -l, E) or equal voluw, es of its solvent (S) on regional vascular 
t.onductances (ml min 100 g-1 rl~.nHg-1). 
Baseline ,~ 0.15 0.30 0.60 1.2 
Subepicardium S 162 +33 169 +38 156 4-16 151 4-11 158 + 9 
E 173 4-17 185 4-15 248 4-19" 369 4-37* 450 ±40* 
Subendocardium S 203 4- 35 198 4- 38 196 4-17 196 4-15 194 + 10 
E 209 4-36 406 4-20 507 4-47 523 +47* 412 +44* 
Total brain S 37 4- 5 41 4- 3 36 4- 3 36 4- 3 35 4- 3 
E 37 + 2 42 4- 3 67 4- 6"  129 4- 7 ~ 163 +12" 
M. pectoralis S 2.5 4- 0.7 2.3 4- 0.7 2.2 4- 0.4 1.7 + 0.2 1.8 + 0.3 
E 2.24- 0.2 2.1+ 0.3 2.74- 0.3 3.44- 0.4 * 4.84- 0.8 * 
Kidneys S 289 4- 31 314 4- 25 295 ~ 34 279 ± 31 267 ± 17 
E 278 4- 23 274 +17 335 4- 33 388 4- 33 319 ±34 
Adrenals S 153 4-22 172 4-14 164 4-11 160 4-14 167 ±19 
E 204 4-32 270 ±30 516 4-36* 583 4-42* 545 ±44* 
Skin S 2.2 4- 0.7 2.2 + 1.2 !.8 4- 0.5 2.3 4- 0.8 2.8 4- 1.3 
E 2.74- 0.5 3.3+ 0.7 3.64- 0.9 5.14- 0.7 * 5.84- 0.6 * 
data are means 4- sem; * EMD 52692-induced changes versus baseline are significantly different from solvent-induced changes 
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mmHg.min ! -t  to 15 _ 2 mmHg.min 1-~), since cardiac output (baseline 3.0 4. 0.2 1 rain -1) did not change. The EM 
52692-induced increase in heart rate from 103 4-7 beats min -1 to 151 4- 13 beats min - l  may be due to reflex 
activation of the sympathetic nervous ystem. Left ventricular end diastolic pressure dose-dependently decreased from 
6 4. 1 mmHg to 3 4. 1 mmHg causing a fall in stroke volume from 30 4. 2 ml to 21 4. 2 ml (P < 0.05). Table 1 shows 
that vasodilatation was not the same for all organs and that in particular the vascular conductance of the cerebral 
vessels increased. In spite of the 20~ decrease in myocardial oxygen consumption there was an increase in left 
ventricular blood flow, which was however only confined to the subepicardial layers. It is concluded that EM 52692 is 
a very potent vasodilator, especially of the cerebral vasculature. 
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In addition to previous results from our laboratory showing that nicorandil relaxed vascular smooth muscle by 
increasing cyclic GMP (cGMP) levels, it was found that it also activated K-channels, an effect which also leads to 
relaxation. In the present study it was attempted to differentiate quantitatively between these two effects in isolated 
bovine coronary arterial strips with simult~aeous isotonic measurement of length and RIA-determination of cGMP. 
When the strips were contracted by the thromboxan analogue U 46619 (1/tM) in the presence of 10/LM methylene 
blue nicorandil produced 30-50~ relaxation without significant changes in cGMP. 
When in U 46619 contracted strips the hyperpolarizing effect of nicorandil was suppressed by raising extracellular 
K ÷ to the 30-fold control value (80 mM), or by addition of 10 mM Ba ++, nicorandil only caused 52~ and 40~ 
relaxation, respectively, whereas cGMP-rises were not significantly suppressed. 
Quantitative separation of both mechanisms of relaxation by nicorandil was further achieved through calculation of 
the cGMP mediated component from a correlation between rises in cGMP and percent relaxation as produced by 
nicorandil under conditions of inhibited hyperpolarization, i.e. in strips contracted with 1 ~tM U 46619 or 10 × K ÷ 
and exposed to either 30-fold K ÷ (80 mM) or 10 mM Ba ÷+. Under both conditions imilar correlations between 
cGMP and relaxation were obtained. 
The cGMP mediated part was 20~ at low concentrations of 40-100 pM to 40~ at high concentrations of 0.47-1.4 
mM of the total relaxation produced by nicorandil in U 46619 contracted strips. Since U 46619 in addition to its 
contractde ffect antagonized the relaxation by nicorandil to some extent without changing cGMP, the correlation 
when corrected for this effect yielded a participation of cGMP in the overall relaxant response of 40~ at low 
concentrations to 85~ at high concentrations of nicorandil. 
The existence of two independent effects was also demonstrated by calculating the dose response curves for 
independent and for additive effects of the cGMP-activators nitroglycerin, nitroprusside-Na, nitrosoglutathion and 
SIN-1 in the presence of one concentration of 20 or 50/tM nicorandil. In all of these cases the independence of the 
effect of added nicorandil from the effect of the respective nitrocompound could be demonstrated. 
These results indicate that nicorandil at low concentrations mainly relaxes by hyperpolarization whereas higher 
concentrations mainly relax through cGMP. 
